Form 4: Intellicheck CFO, COO Jeffrey Ishmael Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Jeffrey Ishmael, CFO and COO of Intellicheck, Inc., reports the acquisition of stock options with varying exercise prices and vesting schedules.

Summary

  • On March 15, 2024, Jeffrey Ishmael, the CFO and COO of Intellicheck, Inc., acquired stock options.
  • These options are rights to buy Intellicheck's common stock.
  • The options are divided into three tranches with exercise prices of $1.81, $1.99, and $2.17.
  • Each tranche consists of 45,000, 22,500, and 22,500 options respectively.
  • The options vest over a three-year period, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds vesting quarterly over the following two years.
  • The expiration date for all options is March 15, 2031.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates alignment of management with shareholder interests through stock options.

Positives

  • The acquisition of stock options by a key executive can be seen as a positive sign, aligning the executive's interests with those of the shareholders.

Industry Context

Stock option grants are a common form of executive compensation in the technology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages, particularly in growth-oriented technology companies like Intellicheck.
  • The vesting schedule of one-third after one year and the remainder quarterly over the next two years is a typical vesting structure.
  • Comparable companies such as Mitek Systems or Aware, Inc. also utilize stock options as part of their executive compensation plans.

Stakeholder Impact

  • Shareholders may view the stock option grant as a positive incentive for the CFO/COO to drive company performance.
  • Employees may see this as a sign of confidence in the company's future.

Key Dates

DateDescription
03/15/2024Date of the stock option grant.
03/15/2025First vesting date for one-third of the options.
03/15/2031Expiration date of the stock options.
03/19/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.